Provention Bio Inc. (PRVB) NASDAQ
$24.98 - (-)
Market Cap: -
As of 04/26/23 12:00 AM EDT. Market closed.
Provention Bio Inc. (PRVB)
NASDAQ
$24.98
- (-)
Market Cap: -
As of 04/26/23 12:00 AM EDT. Market closed.
Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed ... read more
Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed by the U.S. Food and Drug Administration (FDA). The Company's pipeline includes additional clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in other autoimmune diseases, including celiac disease and lupus. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Sessa Capital (Master), L.P. | 10% Owner | Apr 14, 2023 | Sale | $24.32 | 2,190,549 | 53,274,151 | 15,567,497 | Apr 18, 2023, 08:57 PM |
Sessa Capital (Master), L.P. | 10% Owner | Apr 14, 2023 | Option Exercise | $6.00 | 8,879,023 | 53,274,138 | 17,758,046 | Apr 18, 2023, 08:57 PM |
Leon Francisco | Chief Scientific Officer | Feb 13, 2023 | Option Exercise | $2.50 | 25,985 | 64,963 | 1,598,985 | Feb 14, 2023, 07:19 PM |
Leon Francisco | Chief Scientific Officer | Feb 10, 2023 | Option Exercise | $2.50 | 50,000 | 125,000 | 1,623,000 | Feb 14, 2023, 07:19 PM |
Leon Francisco | Chief Scientific Officer | Feb 13, 2023 | Sale | $10.04 | 25,985 | 260,944 | 1,573,000 | Feb 14, 2023, 07:19 PM |
Leon Francisco | Chief Scientific Officer | Feb 10, 2023 | Sale | $10.11 | 50,000 | 505,605 | 1,573,000 | Feb 14, 2023, 07:19 PM |
Hoitt Jason | Chief Commercial Officer | Feb 10, 2023 | Sale | $10.00 | 4,500 | 45,005 | 0 | Feb 14, 2023, 07:16 PM |
Palmer Ashleigh | Director and CEO | Feb 13, 2023 | Option Exercise | $2.50 | 25,835 | 64,588 | 2,595,885 | Feb 14, 2023, 07:13 PM |
Palmer Ashleigh | Director and CEO | Feb 10, 2023 | Option Exercise | $2.50 | 50,000 | 125,000 | 2,620,050 | Feb 14, 2023, 07:13 PM |
Palmer Ashleigh | Director and CEO | Feb 13, 2023 | Sale | $10.04 | 25,835 | 259,448 | 2,570,050 | Feb 14, 2023, 07:13 PM |
Palmer Ashleigh | Director and CEO | Feb 10, 2023 | Sale | $10.11 | 50,000 | 505,555 | 2,570,050 | Feb 14, 2023, 07:13 PM |
Palmer Ashleigh | Director and CEO | Jan 18, 2023 | Option Exercise | $2.50 | 24,165 | 60,413 | 2,594,215 | Jan 20, 2023, 08:00 PM |
Palmer Ashleigh | Director and CEO | Jan 18, 2023 | Sale | $10.27 | 24,165 | 248,063 | 2,570,050 | Jan 20, 2023, 08:00 PM |
Leon Francisco | Chief Scientific Officer | Jan 18, 2023 | Option Exercise | $2.50 | 24,015 | 60,038 | 1,597,015 | Jan 20, 2023, 08:00 PM |
Leon Francisco | Chief Scientific Officer | Jan 18, 2023 | Sale | $10.27 | 24,015 | 246,584 | 1,573,000 | Jan 20, 2023, 08:00 PM |
Sessa Capital (Master), L.P. | 10% Owner | Jan 18, 2023 | Sale | $9.40 | 3,000,000 | 28,199,999 | 11,879,023 | Jan 20, 2023, 04:10 PM |
Leon Francisco | Chief Scientific Officer | Dec 29, 2022 | Option Exercise | $2.50 | 187,000 | 467,500 | 1,760,000 | Dec 30, 2022, 04:01 PM |
Leon Francisco | Chief Scientific Officer | Dec 29, 2022 | Sale | $10.26 | 187,000 | 1,918,601 | 1,573,000 | Dec 30, 2022, 04:01 PM |
Leon Francisco | Chief Scientific Officer | Dec 27, 2022 | Option Exercise | $2.50 | 10,674 | 26,685 | 1,583,674 | Dec 29, 2022, 04:01 PM |
Leon Francisco | Chief Scientific Officer | Dec 27, 2022 | Sale | $10.00 | 10,674 | 106,740 | 1,573,000 | Dec 29, 2022, 04:01 PM |
Leon Francisco | Chief Scientific Officer | Dec 23, 2022 | Option Exercise | $2.50 | 375 | 938 | 1,573,375 | Dec 27, 2022, 05:51 PM |
Leon Francisco | Chief Scientific Officer | Dec 22, 2022 | Option Exercise | $2.50 | 1,568 | 3,920 | 1,574,568 | Dec 27, 2022, 05:51 PM |
Leon Francisco | Chief Scientific Officer | Dec 23, 2022 | Sale | $10.00 | 375 | 3,750 | 1,573,000 | Dec 27, 2022, 05:51 PM |
Leon Francisco | Chief Scientific Officer | Dec 22, 2022 | Sale | $10.00 | 1,568 | 15,681 | 1,573,000 | Dec 27, 2022, 05:51 PM |
Ramos Eleanor | Chief Medical Officer | Dec 03, 2021 | Buy | $6.49 | 5,201 | 33,765 | 70,000 | Dec 06, 2021, 09:28 PM |
Palmer Ashleigh | Director and CEO | Nov 30, 2021 | Buy | $6.66 | 3,750 | 24,990 | 2,570,050 | Dec 01, 2021, 09:21 PM |
Leon Francisco | Chief Scientific Officer | Nov 24, 2021 | Buy | $7.24 | 5,550 | 40,188 | 2,573,000 | Nov 29, 2021, 05:15 PM |
Ramos Eleanor | Chief Medical Officer | Sep 02, 2020 | Buy | $12.06 | 299 | 3,606 | 64,799 | Sep 02, 2020, 07:43 PM |
Drechsler Andrew T | Chief Financial Officer | Sep 02, 2020 | Buy | $11.72 | 2,000 | 23,440 | 20,000 | Sep 02, 2020, 05:00 PM |
Leon Francisco | Chief Scientific Officer | Aug 21, 2020 | Buy | $13.35 | 2,000 | 26,708 | 2,567,450 | Aug 21, 2020, 04:05 PM |
Ramos Eleanor | Chief Medical Officer | Aug 20, 2020 | Buy | $13.23 | 2,500 | 33,075 | 64,500 | Aug 20, 2020, 06:52 PM |
Palmer Ashleigh | President and CEO | Aug 18, 2020 | Buy | $12.69 | 500 | 6,345 | 2,566,300 | Aug 18, 2020, 06:10 PM |
Palmer Ashleigh | President and CEO | Aug 17, 2020 | Buy | $12.83 | 2,800 | 35,924 | 2,565,800 | Aug 17, 2020, 07:20 PM |
Drechsler Andrew T | Chief Financial Officer | Aug 13, 2020 | Buy | $13.01 | 1,750 | 22,768 | 18,000 | Aug 13, 2020, 07:01 PM |
Leon Francisco | Chief Scientific Officer | Jun 24, 2020 | Buy | $15.43 | 2,000 | 30,862 | 2,565,450 | Jun 24, 2020, 04:22 PM |
Bluestone Jeffrey | Director | Apr 10, 2020 | Option Exercise | $2.36 | 32,246 | 76,101 | 39,571 | Apr 14, 2020, 05:00 PM |
Leon Francisco | Chief Scientific Officer | Mar 19, 2020 | Buy | $5.92 | 10,000 | 59,200 | 2,563,450 | Mar 20, 2020, 06:15 AM |
Hoitt Jason | Chief Commercial Officer | Mar 19, 2020 | Buy | $5.43 | 4,500 | 24,435 | 4,500 | Mar 20, 2020, 06:15 AM |
Ramos Eleanor | CMO & COO | Dec 26, 2019 | Buy | $14.34 | 2,000 | 28,680 | 62,000 | Dec 26, 2019, 05:00 PM |
Palmer Ashleigh | President and CEO | Dec 20, 2019 | Buy | $11.39 | 2,075 | 23,634 | 2,563,000 | Dec 23, 2019, 04:30 PM |
Leon Francisco | Chief Scientific Officer | Dec 16, 2019 | Buy | $11.92 | 2,000 | 23,840 | 2,553,450 | Dec 16, 2019, 05:00 PM |
Leon Francisco | Chief Scientific Officer | Sep 30, 2019 | Buy | $7.67 | 1,450 | 11,122 | 2,551,450 | Sep 30, 2019, 05:00 PM |
DIGIANDOMENICO ANTHONY | Director | Sep 30, 2019 | Buy | $6.83 | 30,000 | 204,900 | 178,712 | Sep 30, 2019, 05:00 PM |
DIGIANDOMENICO ANTHONY | Director | Sep 26, 2019 | Buy | $8.44 | 5,000 | 42,200 | 148,712 | Sep 26, 2019, 06:08 PM |
DIGIANDOMENICO ANTHONY | Director | Sep 25, 2019 | Buy | $8.39 | 5,000 | 41,950 | 143,712 | Sep 25, 2019, 05:45 PM |
Palmer Ashleigh | President and CEO | Sep 24, 2019 | Buy | $8.38 | 3,000 | 25,140 | 2,560,925 | Sep 24, 2019, 07:04 PM |
DIGIANDOMENICO ANTHONY | Director | Aug 08, 2019 | Buy | $9.09 | 10,000 | 90,900 | 138,712 | Aug 09, 2019, 06:01 AM |
Leon Francisco | Chief Scientific Officer | Aug 08, 2019 | Buy | $9.09 | 2,500 | 22,725 | 2,550,000 | Aug 09, 2019, 06:01 AM |
Palmer Ashleigh | President and CEO | Aug 08, 2019 | Buy | $9.15 | 10,600 | 96,990 | 2,557,925 | Aug 09, 2019, 06:01 AM |
DIGIANDOMENICO ANTHONY | Director | Jun 20, 2019 | Buy | $10.96 | 10,000 | 109,600 | 128,712 | Jun 20, 2019, 05:37 PM |
DIGIANDOMENICO ANTHONY | Director | Jun 18, 2019 | Buy | $10.88 | 10,000 | 108,800 | 118,712 | Jun 18, 2019, 09:00 PM |
Palmer Ashleigh | President and CEO | Jun 18, 2019 | Buy | $10.83 | 4,000 | 43,320 | 2,547,325 | Jun 18, 2019, 09:00 PM |
Bluestone Jeffrey | Director | Jun 17, 2019 | Sale | $11.93 | 7,300 | 87,089 | 7,325 | Jun 17, 2019, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Jun 17, 2019 | Buy | $12.16 | 25,000 | 304,000 | 108,712 | Jun 17, 2019, 06:00 PM |
Leon Francisco | Chief Scientific Officer | Dec 31, 2018 | Buy | $1.64 | 10,000 | 16,400 | 2,547,500 | Jan 02, 2019, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 28, 2018 | Buy | $1.76 | 10,000 | 17,600 | 83,712 | Dec 31, 2018, 06:00 PM |
Palmer Ashleigh | President and CEO | Dec 31, 2018 | Buy | $1.58 | 825 | 1,304 | 2,543,325 | Dec 31, 2018, 06:00 PM |
Palmer Ashleigh | President and CEO | Dec 28, 2018 | Buy | $1.73 | 5,000 | 8,650 | 2,542,500 | Dec 31, 2018, 06:00 PM |
Pisano Wayne | Director | Dec 28, 2018 | Buy | $1.80 | 5,000 | 9,000 | 7,500 | Dec 31, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 27, 2018 | Buy | $1.95 | 20,000 | 39,000 | 73,712 | Dec 28, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 24, 2018 | Buy | $1.92 | 17,270 | 33,158 | 53,712 | Dec 27, 2018, 06:00 PM |
CATLIN AVERY W | Director | Dec 26, 2018 | Buy | $1.85 | 5,000 | 9,250 | 20,000 | Dec 27, 2018, 06:00 PM |
CATLIN AVERY W | Director | Dec 24, 2018 | Buy | $1.90 | 5,000 | 9,500 | 15,000 | Dec 27, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 21, 2018 | Buy | $1.85 | 2,000 | 3,700 | 36,442 | Dec 26, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 20, 2018 | Buy | $1.96 | 5,000 | 9,800 | 34,442 | Dec 21, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 03, 2018 | Buy | $2.45 | 4,442 | 10,883 | 29,442 | Dec 06, 2018, 06:00 PM |
DIGIANDOMENICO ANTHONY | Director | Nov 30, 2018 | Buy | $2.45 | 4,849 | 11,880 | 25,000 | Dec 03, 2018, 07:13 PM |
DIGIANDOMENICO ANTHONY | Director | Nov 29, 2018 | Buy | $2.47 | 151 | 373 | 20,151 | Dec 03, 2018, 07:13 PM |
DIGIANDOMENICO ANTHONY | Director | Nov 27, 2018 | Buy | $2.46 | 10,000 | 24,600 | 20,000 | Nov 28, 2018, 06:11 PM |
DIGIANDOMENICO ANTHONY | Director | Nov 26, 2018 | Buy | $2.65 | 10,000 | 26,500 | 10,000 | Nov 27, 2018, 06:00 PM |
Drechsler Andrew T | Chief Financial Officer | Nov 13, 2018 | Option Exercise | $2.50 | 10,000 | 25,000 | 16,250 | Nov 14, 2018, 08:00 PM |
CATLIN AVERY W | Director | Nov 09, 2018 | Buy | $3.15 | 10,000 | 31,500 | 10,000 | Nov 13, 2018, 07:00 AM |
APPEL PETER A | 10% Owner | Jul 19, 2018 | Buy | $4.00 | 750,000 | 3,000,000 | 1,950,000 | Jul 26, 2018, 04:50 PM |
Pisano Wayne | Director | Jul 19, 2018 | Buy | $4.00 | 2,500 | 10,000 | 2,500 | Jul 19, 2018, 05:59 PM |
Palmer Ashleigh | President and CEO | Jul 19, 2018 | Buy | $4.00 | 37,500 | 150,000 | 2,537,500 | Jul 19, 2018, 05:58 PM |
Leon Francisco | Chief Scientific Officer | Jul 19, 2018 | Buy | $4.00 | 37,500 | 150,000 | 2,537,500 | Jul 19, 2018, 05:58 PM |
Drechsler Andrew T | Chief Financial Officer | Jul 19, 2018 | Buy | $4.00 | 6,250 | 25,000 | 6,250 | Jul 19, 2018, 05:56 PM |
Ramos Eleanor | Chief Medical Officer & COO | Jul 19, 2018 | Buy | $4.00 | 60,000 | 240,000 | 60,000 | Jul 19, 2018, 05:55 PM |
Owner | Relationship | Date | Value($) |
Sessa Capital (Master), L.P. | 10% Owner | 04/14/2023 | 53,274,151 |
Sessa Capital (Master), L.P. | 10% Owner | 04/14/2023 | 53,274,138 |
Leon Francisco | Chief Scientific Officer | 02/13/2023 | 64,963 |
Leon Francisco | Chief Scientific Officer | 02/10/2023 | 125,000 |
Leon Francisco | Chief Scientific Officer | 02/13/2023 | 260,944 |
Leon Francisco | Chief Scientific Officer | 02/10/2023 | 505,605 |
Hoitt Jason | Chief Commercial Officer | 02/10/2023 | 45,005 |
Palmer Ashleigh | Director and CEO | 02/13/2023 | 64,588 |
Palmer Ashleigh | Director and CEO | 02/10/2023 | 125,000 |
Palmer Ashleigh | Director and CEO | 02/13/2023 | 259,448 |
Palmer Ashleigh | Director and CEO | 02/10/2023 | 505,555 |
Palmer Ashleigh | Director and CEO | 01/18/2023 | 60,413 |
Palmer Ashleigh | Director and CEO | 01/18/2023 | 248,063 |
Leon Francisco | Chief Scientific Officer | 01/18/2023 | 60,038 |
Leon Francisco | Chief Scientific Officer | 01/18/2023 | 246,584 |
Sessa Capital (Master), L.P. | 10% Owner | 01/18/2023 | 28,199,999 |
Leon Francisco | Chief Scientific Officer | 12/29/2022 | 467,500 |
Leon Francisco | Chief Scientific Officer | 12/29/2022 | 1,918,601 |
Leon Francisco | Chief Scientific Officer | 12/27/2022 | 26,685 |
Leon Francisco | Chief Scientific Officer | 12/27/2022 | 106,740 |
Leon Francisco | Chief Scientific Officer | 12/23/2022 | 938 |
Leon Francisco | Chief Scientific Officer | 12/22/2022 | 3,920 |
Leon Francisco | Chief Scientific Officer | 12/23/2022 | 3,750 |
Leon Francisco | Chief Scientific Officer | 12/22/2022 | 15,681 |
Ramos Eleanor | Chief Medical Officer | 12/03/2021 | 33,765 |
Palmer Ashleigh | Director and CEO | 11/30/2021 | 24,990 |
Leon Francisco | Chief Scientific Officer | 11/24/2021 | 40,188 |
Ramos Eleanor | Chief Medical Officer | 09/02/2020 | 3,606 |
Drechsler Andrew T | Chief Financial Officer | 09/02/2020 | 23,440 |
Leon Francisco | Chief Scientific Officer | 08/21/2020 | 26,708 |
Ramos Eleanor | Chief Medical Officer | 08/20/2020 | 33,075 |
Palmer Ashleigh | President and CEO | 08/18/2020 | 6,345 |
Palmer Ashleigh | President and CEO | 08/17/2020 | 35,924 |
Drechsler Andrew T | Chief Financial Officer | 08/13/2020 | 22,768 |
Leon Francisco | Chief Scientific Officer | 06/24/2020 | 30,862 |
Bluestone Jeffrey | Director | 04/10/2020 | 76,101 |
Leon Francisco | Chief Scientific Officer | 03/19/2020 | 59,200 |
Hoitt Jason | Chief Commercial Officer | 03/19/2020 | 24,435 |
Ramos Eleanor | CMO & COO | 12/26/2019 | 28,680 |
Palmer Ashleigh | President and CEO | 12/20/2019 | 23,634 |
Leon Francisco | Chief Scientific Officer | 12/16/2019 | 23,840 |
Leon Francisco | Chief Scientific Officer | 09/30/2019 | 11,122 |
DIGIANDOMENICO ANTHONY | Director | 09/30/2019 | 204,900 |
DIGIANDOMENICO ANTHONY | Director | 09/26/2019 | 42,200 |
DIGIANDOMENICO ANTHONY | Director | 09/25/2019 | 41,950 |
Palmer Ashleigh | President and CEO | 09/24/2019 | 25,140 |
DIGIANDOMENICO ANTHONY | Director | 08/08/2019 | 90,900 |
Leon Francisco | Chief Scientific Officer | 08/08/2019 | 22,725 |
Palmer Ashleigh | President and CEO | 08/08/2019 | 96,990 |
DIGIANDOMENICO ANTHONY | Director | 06/20/2019 | 109,600 |
DIGIANDOMENICO ANTHONY | Director | 06/18/2019 | 108,800 |
Palmer Ashleigh | President and CEO | 06/18/2019 | 43,320 |
Bluestone Jeffrey | Director | 06/17/2019 | 87,089 |
DIGIANDOMENICO ANTHONY | Director | 06/17/2019 | 304,000 |
Leon Francisco | Chief Scientific Officer | 12/31/2018 | 16,400 |
DIGIANDOMENICO ANTHONY | Director | 12/28/2018 | 17,600 |
Palmer Ashleigh | President and CEO | 12/31/2018 | 1,304 |
Palmer Ashleigh | President and CEO | 12/28/2018 | 8,650 |
Pisano Wayne | Director | 12/28/2018 | 9,000 |
DIGIANDOMENICO ANTHONY | Director | 12/27/2018 | 39,000 |
DIGIANDOMENICO ANTHONY | Director | 12/24/2018 | 33,158 |
CATLIN AVERY W | Director | 12/26/2018 | 9,250 |
CATLIN AVERY W | Director | 12/24/2018 | 9,500 |
DIGIANDOMENICO ANTHONY | Director | 12/21/2018 | 3,700 |
DIGIANDOMENICO ANTHONY | Director | 12/20/2018 | 9,800 |
DIGIANDOMENICO ANTHONY | Director | 12/03/2018 | 10,883 |
DIGIANDOMENICO ANTHONY | Director | 11/30/2018 | 11,880 |
DIGIANDOMENICO ANTHONY | Director | 11/29/2018 | 373 |
DIGIANDOMENICO ANTHONY | Director | 11/27/2018 | 24,600 |
DIGIANDOMENICO ANTHONY | Director | 11/26/2018 | 26,500 |
Drechsler Andrew T | Chief Financial Officer | 11/13/2018 | 25,000 |
CATLIN AVERY W | Director | 11/09/2018 | 31,500 |
APPEL PETER A | 10% Owner | 07/19/2018 | 3,000,000 |
Pisano Wayne | Director | 07/19/2018 | 10,000 |
Palmer Ashleigh | President and CEO | 07/19/2018 | 150,000 |
Leon Francisco | Chief Scientific Officer | 07/19/2018 | 150,000 |
Drechsler Andrew T | Chief Financial Officer | 07/19/2018 | 25,000 |
Ramos Eleanor | Chief Medical Officer & COO | 07/19/2018 | 240,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ALPINE GLOBAL MANAGEMENT, LLC | 25,150 | 0.24% | Exited | Event Driven |